Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: A Multicenter Study

NCT03021239 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT03021239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03021239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: A Multicenter Study
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
April 30, 2019
Enrollment
40 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

continous flow left ventricular device